Clinical Trials in Rare Diseases

Textbook of Clinical Trials: Second Edition

Volumn , Issue , 2007, Pages 723-734

  Day, Simon ^a  

^a MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY   (United Kingdom)

Author keywords

Biomarkers and surrogate endpoints; Clinical trials in rare diseases; Disease and patient definitions; Slowing disease progression; Trial and patient registers

Indexed keywords

EID: 84890757088     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470010167.ch40     Document Type: Chapter

References (27)

1. Yusuf S, Collins R, Peto R. Why do we need some large, simple randomized trials? Stat Med (1984) 3: 409-20.
2. Powell-Tuck K, MacRae KD, Healy MJ, Lennard-Jones JE, Parkins RA. A defence of the small clinical trial: evaluation of three gastroenterological studies. Br Med J (1986) 292: 599-602.
3. Evans CH, Ildstad ST (eds). Small Clinical Trials: Issues and Challenges. Washington, DC: Institute of Medicine (2001).
4. Sylvester R. European Organization for Research and Treatment of Cancer (EORTC). In: Redmond C, Colton T, eds, Biostatistics in Clinical Trials. Chichester: John Wiley & Sons, Ltd (2001) 191.
5. Noseworthy J, Kapposs L, Daumer M. Competing interests in multiple sclerosis research. Lancet (2003) 361: 350-1.
6. Jadad A. Randomised Controlled Trials. London: BMJ Books (1998).
7. Altman DG, Schulz KF. Concealing treatment allocation in randomised trials. Br Med J (2001) 323: 446-7.
8. ICH Steering Committee. ICH Harmonised tripartite guideline. Choice of Control group in Clinical Trials. European Union, Japan and USA: International Conference on Harmonisation (1999).
9. Johannessen T. Controlled trials in single subjects: 1. Value in clinical medicine. Br Med J, (1991) 303: 173-4.
10. Lewis JA. Controlled trials in single subjects: 2. Limitations of use. Br Med J (1991) 303: 175-6.
11. Day S. Controlled trials in single subjects (letter to the Editor). Br Med J (1991) 303: 522.
12. Maitournam A, Simon R. On the efficiency of targeted clinical trials. Stat Med (2005) 24: 329-39.
13. Keating MJ. The chronic leukemias. In: Bennett JC, Plum F, Cecil Textbook of Medicine. Philadelphia: W B Saunders (1996) 925-35.
14. Appelbaum FR. The acute leukemias. In: Bennett JC, Plum F, Cecil Textbook of Medicine. Philadelphia: W B Saunders (1996) 936-40.
15. Magalini SI, Magalini SC. Dictionary of Medical Syndromes, 4th edn. Philadelphia: Lippincott-Raven (1997).
16. Pérez Fontán JJ, Haddad GG. Respiratory pathophysiology. In: Behrman RE, Kliegman RM, Jenson HB, eds, Nelson Textbook of Paediatrics, 17th edn. Philadelphia: Saunders (2004) 1362-73.
17. Haddad GG, Palazzo RM. Diagnostic approach to respiratory disease. In: Behrman RE, Kliegman RM, Jenson HB, eds, Nelson Textbook of Paediatrics, 17th edn. Philadelphia: Saunders (2004) 1375-9.
18. Fayers PM, Machin D. Quality of Life: Assessment, Analysis and Interpretation. Chichester: John Wiley & Sons, Ltd (2000).
19. Senn S. Regression to the mean (editorial). Stat Methods Med Res (1997) 6: 99-102.
20. Stiger TR, Pun EFC. Placebo effect. In: Chow SC, ed., Encyclopedia of Biopharmaceutical Statistics. New York: Marcel Dekker (2000) 402-7.
21. Whitehead J. The Design and Analysis of Sequential Clinical Trials. Chichester: John Wiley & Sons, Ltd (1997).
22. Liu J. Enrichment design. In: Chow S-C, ed., Encyclopedia of Biopharmaceutical Statistics. New York: Marcel Dekker (2000) 185-8.
23. Tan S-B, Dear KBG, Bruzzi P, Machin D. Strategy for randomised clinical trials in rare cancers. Br Med J (2002) 327: 47-9.
24. Weeden S, Parmar M, Freedman LS. Bayesian reporting of clinical trials. In: Geller NL, ed., Advances in Clinical Trial Biostatistics. NewYork: Marcel Dekker (2004) 161-88.
25. Siegel S, Castellan NJ. Nonparametric Statistics for the Behavioral Sciences, 2nd edn. New York: McGraw-Hill (1998).
26. Heeren T, D'Agostino R. Robustness of the two independent samples t-test when applied to ordinal scaled data. Stat Med (1987) 6: 79-90.
27. Sullivan RB, D'Agostino RB Sr. Robustness and power of analysis of covariance applied to ordinal scaled data arising in randomized controlled trials. Stat Med (2003) 22: 1317-34.